Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J LORD

Showing results (281-290 of 596) with videos related to

Pageof 60
Sort By:
European Journal of Cancer (Oxford, England : 1990)|June 2, 2022
Adverse events in the placebo arm of maintenance therapy trials in advanced ovarian cancer: A systematic review and meta-analysisSandy Simon, Katherine E Francis, Janene E Dalrymple, et al.
The Australian and New Zealand Journal of Surgery|December 1, 1989
Complications associated with penile implants used to treat impotenceC M Earle, G R Watters, A G Tulloch, et al.
Biological Cybernetics|May 31, 2007
Branching dendrites with resonant membrane: a "sum-over-trips" approachS Coombes, Y Timofeeva, C-M Svensson, et al.
JCO Precision Oncology|February 17, 2022
Clinical Equipoise for Trials of Novel Biologic Therapies, Therapeutic Success Rates, and Predictors of Success: A Meta-AnalysisDoah Cho, Felicia T Roncolato, Johnathan Man, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|September 11, 2018
Assessment of NICE and USPSTF guidelines for identifying women at high risk of pre-eclampsia for tailoring aspirin prophylaxis in pregnancy: An individual participant data meta-analysisZiad T A Al-Rubaie, Lisa M Askie, H Malcolm Hudson, et al.
Cancer|January 28, 2022
Pre- and on-treatment lactate dehydrogenase as a prognostic and predictive biomarker in advanced non-small cell lung cancerAngelina Tjokrowidjaja, Sarah J Lord, Thomas John, et al.
Cancer Biology & Therapy|October 28, 2005
BRCA2-deficient CAPAN-1 cells are extremely sensitive to the inhibition of Poly (ADP-Ribose) polymerase: an issue of potencyNuala McCabe, Christopher J Lord, Andrew N J Tutt, et al.
EMBO Reports|December 3, 2005
p53 modulates homologous recombination by transcriptional regulation of the RAD51 geneCarmen Arias-Lopez, Iciar Lazaro-Trueba, Peter Kerr, et al.
Breast (Edinburgh, Scotland)|November 25, 2017
Trastuzumab for metastatic breast cancer: Real world outcomes from an Australian whole-of-population cohort (2001-2016)Benjamin Daniels, Belinda E Kiely, Sarah J Lord, et al.
BMC Medical Research Methodology|February 16, 2012
Using patient management as a surrogate for patient health outcomes in diagnostic test evaluationLukas P Staub, Sarah J Lord, R John Simes, et al.
Pageof 60

Showing results (281-290 of 596) with videos related to

Sort By:
Pageof 60
European Journal of Cancer (Oxford, England : 1990)|June 2, 2022
Adverse events in the placebo arm of maintenance therapy trials in advanced ovarian cancer: A systematic review and meta-analysisSandy Simon, Katherine E Francis, Janene E Dalrymple, et al.
The Australian and New Zealand Journal of Surgery|December 1, 1989
Complications associated with penile implants used to treat impotenceC M Earle, G R Watters, A G Tulloch, et al.
Biological Cybernetics|May 31, 2007
Branching dendrites with resonant membrane: a "sum-over-trips" approachS Coombes, Y Timofeeva, C-M Svensson, et al.
JCO Precision Oncology|February 17, 2022
Clinical Equipoise for Trials of Novel Biologic Therapies, Therapeutic Success Rates, and Predictors of Success: A Meta-AnalysisDoah Cho, Felicia T Roncolato, Johnathan Man, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|September 11, 2018
Assessment of NICE and USPSTF guidelines for identifying women at high risk of pre-eclampsia for tailoring aspirin prophylaxis in pregnancy: An individual participant data meta-analysisZiad T A Al-Rubaie, Lisa M Askie, H Malcolm Hudson, et al.
Cancer|January 28, 2022
Pre- and on-treatment lactate dehydrogenase as a prognostic and predictive biomarker in advanced non-small cell lung cancerAngelina Tjokrowidjaja, Sarah J Lord, Thomas John, et al.
Cancer Biology & Therapy|October 28, 2005
BRCA2-deficient CAPAN-1 cells are extremely sensitive to the inhibition of Poly (ADP-Ribose) polymerase: an issue of potencyNuala McCabe, Christopher J Lord, Andrew N J Tutt, et al.
EMBO Reports|December 3, 2005
p53 modulates homologous recombination by transcriptional regulation of the RAD51 geneCarmen Arias-Lopez, Iciar Lazaro-Trueba, Peter Kerr, et al.
Breast (Edinburgh, Scotland)|November 25, 2017
Trastuzumab for metastatic breast cancer: Real world outcomes from an Australian whole-of-population cohort (2001-2016)Benjamin Daniels, Belinda E Kiely, Sarah J Lord, et al.
BMC Medical Research Methodology|February 16, 2012
Using patient management as a surrogate for patient health outcomes in diagnostic test evaluationLukas P Staub, Sarah J Lord, R John Simes, et al.
Pageof 60